Astellas Pharma Inc
TSE:4503
Astellas Pharma Inc
TSE:4503
Price:
1 530.5
JPY
0.76%
Market Closed
Market Cap:
2.8T
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Astellas Pharma Inc
1530.5
+11.5 (+0.76%)
| 52 Week Range |
1 446
1 828
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Astellas Pharma Inc
Income Statement
Earnings Waterfall
Astellas Pharma Inc
Astellas Pharma Inc
|
Revenue
|
1.8T
JPY
|
|
Cost of Revenue
|
-323B
JPY
|
|
Gross Profit
|
1.4T
JPY
|
|
Operating Expenses
|
-1.3T
JPY
|
|
Operating Income
|
120.4B
JPY
|
|
Other Expenses
|
-65.7B
JPY
|
|
Net Income
|
54.7B
JPY
|
Income Statement
Astellas Pharma Inc
Astellas Pharma Inc
Currency: JPY
| Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
1 190 283
N/A
|
1 224 418
+3%
|
1 247 259
+2%
|
1 295 761
+4%
|
1 340 307
+3%
|
1 360 153
+1%
|
1 372 706
+1%
|
1 366 799
0%
|
1 336 878
-2%
|
1 312 627
-2%
|
1 311 665
0%
|
1 296 484
-1%
|
1 299 746
+0%
|
1 305 521
+0%
|
1 300 316
0%
|
1 306 830
+1%
|
1 307 658
+0%
|
1 305 901
0%
|
1 306 348
+0%
|
1 311 397
+0%
|
1 309 722
0%
|
1 289 855
-2%
|
1 300 843
+1%
|
1 273 678
-2%
|
1 265 854
-1%
|
1 253 216
-1%
|
1 249 528
0%
|
1 268 703
+2%
|
1 285 714
+1%
|
1 300 914
+1%
|
1 296 163
0%
|
1 351 811
+4%
|
1 406 682
+4%
|
1 468 235
+4%
|
1 518 619
+3%
|
1 511 818
0%
|
1 898 562
+26%
|
1 918 314
+1%
|
1 603 672
-16%
|
2 076 796
+30%
|
1 772 155
-15%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(329 011)
|
(329 429)
|
(333 197)
|
(347 293)
|
(342 500)
|
(344 211)
|
(335 596)
|
(316 982)
|
(313 408)
|
(315 867)
|
(320 503)
|
(328 310)
|
(323 113)
|
(308 665)
|
(294 250)
|
(285 714)
|
(288 974)
|
(283 036)
|
(292 050)
|
(291 826)
|
(287 382)
|
(285 980)
|
(276 739)
|
(265 880)
|
(257 416)
|
(242 834)
|
(246 063)
|
(248 641)
|
(251 249)
|
(252 421)
|
(253 009)
|
(279 648)
|
(279 925)
|
(284 988)
|
(288 353)
|
(268 430)
|
(349 008)
|
(350 483)
|
(292 485)
|
(383 621)
|
(322 951)
|
|
| Gross Profit |
861 272
N/A
|
894 989
+4%
|
914 062
+2%
|
948 468
+4%
|
997 807
+5%
|
1 015 942
+2%
|
1 037 110
+2%
|
1 049 817
+1%
|
1 023 470
-3%
|
996 760
-3%
|
991 162
-1%
|
968 174
-2%
|
976 633
+1%
|
996 856
+2%
|
1 006 066
+1%
|
1 021 116
+1%
|
1 018 684
0%
|
1 022 865
+0%
|
1 014 298
-1%
|
1 019 571
+1%
|
1 022 340
+0%
|
1 003 875
-2%
|
1 024 104
+2%
|
1 007 798
-2%
|
1 008 438
+0%
|
1 010 382
+0%
|
1 003 465
-1%
|
1 020 062
+2%
|
1 034 465
+1%
|
1 048 493
+1%
|
1 043 154
-1%
|
1 072 163
+3%
|
1 126 757
+5%
|
1 183 247
+5%
|
1 230 266
+4%
|
1 243 388
+1%
|
1 549 554
+25%
|
1 567 831
+1%
|
1 311 187
-16%
|
1 693 175
+29%
|
1 449 204
-14%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(697 850)
|
(721 545)
|
(703 425)
|
(747 654)
|
(778 550)
|
(772 392)
|
(769 930)
|
(761 427)
|
(741 285)
|
(723 031)
|
(717 349)
|
(761 817)
|
(781 801)
|
(792 508)
|
(728 372)
|
(765 765)
|
(751 871)
|
(757 267)
|
(726 069)
|
(760 018)
|
(740 644)
|
(728 972)
|
(756 622)
|
(779 119)
|
(839 245)
|
(844 831)
|
(752 533)
|
(883 479)
|
(870 119)
|
(884 772)
|
(825 009)
|
(858 091)
|
(896 512)
|
(962 222)
|
(998 614)
|
(1 041 431)
|
(1 364 147)
|
(1 425 787)
|
(1 186 580)
|
(1 562 582)
|
(1 328 764)
|
|
| Selling, General & Administrative |
(414 273)
|
(431 242)
|
(452 522)
|
(474 276)
|
(490 493)
|
(497 984)
|
(500 359)
|
(493 582)
|
(481 460)
|
(474 335)
|
(470 777)
|
(471 227)
|
(478 249)
|
(484 126)
|
(478 330)
|
(478 883)
|
(481 546)
|
(484 099)
|
(490 263)
|
(494 845)
|
(484 799)
|
(488 053)
|
(499 295)
|
(502 600)
|
(515 363)
|
(508 764)
|
(504 316)
|
(520 649)
|
(532 687)
|
(547 692)
|
(548 840)
|
(565 127)
|
(586 290)
|
(613 398)
|
(630 272)
|
(645 059)
|
(874 709)
|
(907 566)
|
(773 544)
|
(980 421)
|
(795 745)
|
|
| Research & Development |
(198 064)
|
(200 906)
|
(206 594)
|
(214 931)
|
(221 608)
|
(223 590)
|
(225 665)
|
(220 707)
|
(213 295)
|
(208 958)
|
(208 129)
|
(213 584)
|
(215 938)
|
(221 463)
|
(220 781)
|
(216 436)
|
(212 866)
|
(209 116)
|
(208 682)
|
(210 056)
|
(214 090)
|
(218 477)
|
(224 226)
|
(228 007)
|
(230 952)
|
(233 292)
|
(224 489)
|
(225 513)
|
(231 848)
|
(233 316)
|
(246 010)
|
(261 704)
|
(266 127)
|
(274 414)
|
(276 128)
|
(266 713)
|
(343 490)
|
(351 002)
|
(294 187)
|
(381 008)
|
(324 570)
|
|
| Depreciation & Amortization |
(36 154)
|
(37 161)
|
(38 664)
|
(40 682)
|
(42 636)
|
(43 800)
|
(42 387)
|
(40 487)
|
(38 191)
|
(35 979)
|
(35 837)
|
(35 826)
|
(36 066)
|
(36 089)
|
(35 838)
|
(35 906)
|
(35 571)
|
(35 331)
|
(35 212)
|
(33 352)
|
(28 744)
|
(24 162)
|
(21 164)
|
(19 841)
|
(21 513)
|
(23 021)
|
(23 763)
|
(23 871)
|
(24 593)
|
(26 716)
|
(28 283)
|
(33 065)
|
(35 872)
|
(37 211)
|
(38 436)
|
(36 760)
|
(61 270)
|
(84 503)
|
(98 820)
|
(133 812)
|
(134 318)
|
|
| Other Operating Expenses |
(49 359)
|
(52 236)
|
(5 645)
|
(17 765)
|
(23 813)
|
(7 018)
|
(1 519)
|
(6 651)
|
(8 339)
|
(3 759)
|
(2 606)
|
(41 180)
|
(51 548)
|
(50 830)
|
6 577
|
(34 540)
|
(21 888)
|
(28 721)
|
8 088
|
(21 765)
|
(13 011)
|
1 720
|
(11 937)
|
(28 671)
|
(71 417)
|
(79 754)
|
35
|
(113 446)
|
(80 991)
|
(77 048)
|
(1 876)
|
1 805
|
(8 223)
|
(37 199)
|
(53 778)
|
(92 899)
|
(84 678)
|
(82 716)
|
(20 029)
|
(67 341)
|
(74 131)
|
|
| Operating Income |
163 422
N/A
|
173 444
+6%
|
210 637
+21%
|
200 814
-5%
|
219 257
+9%
|
243 550
+11%
|
267 180
+10%
|
288 390
+8%
|
282 185
-2%
|
273 729
-3%
|
273 813
+0%
|
206 357
-25%
|
194 832
-6%
|
204 348
+5%
|
277 694
+36%
|
255 351
-8%
|
266 813
+4%
|
265 598
0%
|
288 229
+9%
|
259 553
-10%
|
281 696
+9%
|
274 903
-2%
|
267 482
-3%
|
228 679
-15%
|
169 193
-26%
|
165 551
-2%
|
250 932
+52%
|
136 583
-46%
|
164 346
+20%
|
163 721
0%
|
218 145
+33%
|
214 072
-2%
|
230 245
+8%
|
221 025
-4%
|
231 652
+5%
|
201 957
-13%
|
185 407
-8%
|
142 044
-23%
|
124 607
-12%
|
130 593
+5%
|
120 440
-8%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(3 959)
|
(5 288)
|
3 278
|
6 253
|
13 172
|
12 977
|
4 854
|
(1 098)
|
(8 061)
|
3 477
|
26 623
|
30 699
|
30 390
|
18 129
|
(7 572)
|
(1 419)
|
(1 001)
|
1 364
|
576
|
1 447
|
556
|
419
|
(10 572)
|
380
|
3 664
|
4 841
|
(3 212)
|
10 384
|
7 025
|
5 323
|
7 207
|
14 620
|
18 913
|
16 037
|
(6 829)
|
3 452
|
890
|
1 054
|
(2 544)
|
(1 948)
|
(7 860)
|
|
| Non-Reccuring Items |
0
|
0
|
(24 233)
|
0
|
0
|
0
|
(10 325)
|
0
|
0
|
0
|
(18 707)
|
0
|
0
|
0
|
(52 023)
|
(19 795)
|
(20 625)
|
(20 625)
|
(43 425)
|
0
|
0
|
0
|
(12 903)
|
0
|
0
|
0
|
(102 469)
|
(26 052)
|
(26 054)
|
(20 546)
|
(66 036)
|
(75 959)
|
(60 879)
|
(67 342)
|
(94 766)
|
(57 878)
|
(71 249)
|
(70 495)
|
(95 370)
|
(53 182)
|
(54 889)
|
|
| Total Other Income |
1
|
(1)
|
0
|
2
|
1
|
2
|
61
|
(2)
|
0
|
(1)
|
40
|
0
|
(1)
|
(1)
|
14
|
0
|
0
|
0
|
3 587
|
1
|
0
|
0
|
1 343
|
0
|
0
|
1
|
73
|
0
|
0
|
0
|
(2 430)
|
2
|
0
|
0
|
2 304
|
0
|
0
|
0
|
(1 724)
|
0
|
3
|
|
| Pre-Tax Income |
159 464
N/A
|
168 155
+5%
|
189 683
+13%
|
207 069
+9%
|
232 430
+12%
|
256 529
+10%
|
261 770
+2%
|
287 290
+10%
|
274 124
-5%
|
277 205
+1%
|
281 769
+2%
|
237 056
-16%
|
225 221
-5%
|
222 476
-1%
|
218 113
-2%
|
234 137
+7%
|
245 187
+5%
|
246 337
+0%
|
248 967
+1%
|
261 001
+5%
|
282 253
+8%
|
275 323
-2%
|
245 350
-11%
|
229 059
-7%
|
172 857
-25%
|
170 393
-1%
|
145 324
-15%
|
120 917
-17%
|
145 319
+20%
|
148 499
+2%
|
156 886
+6%
|
152 735
-3%
|
188 281
+23%
|
169 722
-10%
|
132 361
-22%
|
147 532
+11%
|
115 048
-22%
|
72 603
-37%
|
24 969
-66%
|
75 464
+202%
|
57 694
-24%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(44 161)
|
(45 992)
|
(53 827)
|
(62 452)
|
(63 625)
|
(70 870)
|
(68 083)
|
(71 613)
|
(68 306)
|
(69 265)
|
(63 069)
|
(42 500)
|
(39 468)
|
(39 962)
|
(53 434)
|
(57 366)
|
(58 758)
|
(32 735)
|
(26 702)
|
(34 776)
|
(35 326)
|
(54 573)
|
(49 939)
|
(41 754)
|
(33 136)
|
(32 085)
|
(24 734)
|
(20 053)
|
(25 958)
|
(28 332)
|
(32 800)
|
(34 523)
|
(39 369)
|
(33 291)
|
(33 647)
|
(40 501)
|
(43 830)
|
(35 277)
|
(7 924)
|
(20 816)
|
(2 947)
|
|
| Income from Continuing Operations |
115 303
|
122 163
|
135 856
|
144 617
|
168 805
|
185 659
|
193 687
|
215 677
|
205 818
|
207 940
|
218 700
|
194 556
|
185 753
|
182 514
|
164 679
|
176 771
|
186 429
|
213 602
|
222 265
|
226 225
|
246 927
|
220 750
|
195 411
|
187 305
|
139 721
|
138 308
|
120 590
|
100 864
|
119 361
|
120 167
|
124 086
|
118 212
|
148 912
|
136 431
|
98 714
|
107 031
|
71 218
|
37 326
|
17 045
|
54 648
|
54 747
|
|
| Net Income (Common) |
115 301
N/A
|
122 162
+6%
|
135 856
+11%
|
144 617
+6%
|
168 805
+17%
|
185 659
+10%
|
193 687
+4%
|
215 678
+11%
|
205 818
-5%
|
207 940
+1%
|
218 701
+5%
|
194 556
-11%
|
185 754
-5%
|
182 515
-2%
|
164 679
-10%
|
176 770
+7%
|
186 428
+5%
|
213 600
+15%
|
222 265
+4%
|
226 224
+2%
|
246 926
+9%
|
220 751
-11%
|
195 411
-11%
|
187 306
-4%
|
139 722
-25%
|
138 307
-1%
|
120 589
-13%
|
100 863
-16%
|
119 360
+18%
|
120 166
+1%
|
124 086
+3%
|
118 210
-5%
|
148 911
+26%
|
136 431
-8%
|
98 714
-28%
|
107 032
+8%
|
71 219
-33%
|
37 327
-48%
|
17 045
-54%
|
54 648
+221%
|
54 746
+0%
|
|
| EPS (Diluted) |
52.14
N/A
|
55.25
+6%
|
61.4
+11%
|
65.94
+7%
|
77.93
+18%
|
86.27
+11%
|
89.62
+4%
|
101.35
+13%
|
96.71
-5%
|
98.54
+2%
|
103.55
+5%
|
94.12
-9%
|
90.74
-4%
|
90.39
0%
|
81.02
-10%
|
89.59
+11%
|
95.4
+6%
|
111.09
+16%
|
114.94
+3%
|
119.85
+4%
|
130.85
+9%
|
117.66
-10%
|
104.08
-12%
|
100.77
-3%
|
75.17
-25%
|
74.41
-1%
|
64.93
-13%
|
54.4
-16%
|
64.38
+18%
|
64.85
+1%
|
67.05
+3%
|
64.77
-3%
|
81.66
+26%
|
74.81
-8%
|
54.09
-28%
|
59.65
+10%
|
39.56
-34%
|
20.73
-48%
|
9.47
-54%
|
30.43
+221%
|
30.45
+0%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
